Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

OYST

Oyster Point Pharma (OYST)

Oyster Point Pharma Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:OYST
DateHeureSourceTitreSymboleSociété
14/02/202322h34Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OYSTOyster Point Pharma Inc
13/01/202323h11Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:OYSTOyster Point Pharma Inc
13/01/202323h06Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:OYSTOyster Point Pharma Inc
06/01/202312h04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:OYSTOyster Point Pharma Inc
05/01/202322h33Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:OYSTOyster Point Pharma Inc
05/01/202322h32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OYSTOyster Point Pharma Inc
03/01/202315h53Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:OYSTOyster Point Pharma Inc
03/01/202315h26Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:OYSTOyster Point Pharma Inc
03/01/202315h19Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:OYSTOyster Point Pharma Inc
03/01/202315h07Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:OYSTOyster Point Pharma Inc
23/12/202212h31Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:OYSTOyster Point Pharma Inc
22/12/202223h16Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:OYSTOyster Point Pharma Inc
02/12/202214h00GlobeNewswire Inc.Oyster Point Pharma, Inc., Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:OYSTOyster Point Pharma Inc
01/12/202212h12Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:OYSTOyster Point Pharma Inc
16/11/202222h25Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:OYSTOyster Point Pharma Inc
14/11/202214h10Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:OYSTOyster Point Pharma Inc
10/11/202222h15Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:OYSTOyster Point Pharma Inc
10/11/202222h11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OYSTOyster Point Pharma Inc
10/11/202222h05GlobeNewswire Inc.Oyster Point Pharma Reports Third Quarter 2022 Financial Results and Recent Business HighlightsNASDAQ:OYSTOyster Point Pharma Inc
07/11/202214h00GlobeNewswire Inc.Oyster Point Pharma, a Leading Ophthalmology-Focused Biopharmaceutical Company, to be Acquired by ViatrisNASDAQ:OYSTOyster Point Pharma Inc
02/11/202221h02GlobeNewswire Inc.Oyster Point Pharma To Report Third Quarter 2022 Financial Results On November 10, 2022NASDAQ:OYSTOyster Point Pharma Inc
27/09/202214h00GlobeNewswire Inc.Oyster Point Pharma to Present New Scientific Analyses at World Cornea Congress VIIINASDAQ:OYSTOyster Point Pharma Inc
07/09/202223h36GlobeNewswire Inc.Oyster Point Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:OYSTOyster Point Pharma Inc
25/08/202214h00GlobeNewswire Inc.Oyster Point Pharma to Present Analyses at the Women in Ophthalmology Summer SymposiumNASDAQ:OYSTOyster Point Pharma Inc
17/08/202214h00GlobeNewswire Inc.Oyster Point Pharma Announces TYRVAYA® To Be Covered By the Largest Medicare Pharmacy Benefit ManagerNASDAQ:OYSTOyster Point Pharma Inc
15/08/202214h00GlobeNewswire Inc.Oyster Point Pharma To Attend H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference on August 17, 2022NASDAQ:OYSTOyster Point Pharma Inc
11/08/202222h01GlobeNewswire Inc.Oyster Point Pharma Reports Second Quarter 2022 Financial Results and Recent Business HighlightsNASDAQ:OYSTOyster Point Pharma Inc
08/08/202222h03GlobeNewswire Inc.Oyster Point Pharma To Report Second Quarter 2022 Financial Results On August 11, 2022NASDAQ:OYSTOyster Point Pharma Inc
27/07/202213h00GlobeNewswire Inc.Oyster Point Pharma Announces Expanded Patient Access to TYRVAYA®NASDAQ:OYSTOyster Point Pharma Inc
18/07/202212h17TipRanksH.C. Wainwright Thinks Oyster Point Pharma’s Stock is Going to RecoverNASDAQ:OYSTOyster Point Pharma Inc
 Showing the most relevant articles for your search:NASDAQ:OYST